VIAD PHARMA ApS: Financial statements 2020
CVR: 36433892
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
VIAD PHARMA ApS (CVR 36433892) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,290,916 and a net result of DKK 457,510 compared with DKK 554,640 the year before. That is a decrease of 8.5% compared with the year before. Equity in the 2020 report amounted to DKK 525,877. The solvency ratio was 29.7%.
- Gross Profit
- DKK 1,290,916
- Profit/Loss
- DKK 457,510
- Equity
- DKK 525,877
- Total Assets
- DKK 1,768,231
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.3 mio. | 458 t. | 526 t. | - |
| 2019 | - | 1.4 mio. | 555 t. | 668 t. | - |
| 2018 | - | 1.4 mio. | 553 t. | 714 t. | - |
| 2017 | - | 1.5 mio. | 677 t. | 761 t. | - |
| 2016 | - | 1.4 mio. | 623 t. | 684 t. | - |
Official annual report
How creditworthy is VIAD PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
VIAD PHARMA ApS has published its annual report for 2019. Gross profit came to DKK 1,410,155, and the net result was DKK 554,640.
About VIAD PHARMA ApS
VIAD PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Heidi Meier. The company is owned by HEIDI MEIER HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,031,002 and a net result of DKK 168,032 compared with DKK 808,813 the year before. Equity in the 2025 report amounted to DKK 236,399.